Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatic mitochondrial DNA/Toll-like receptor 9/MicroRNA-223 forms a negative feedback loop to limit neutrophil overactivation and acetaminophen hepatotoxicity in mice.

Hepatology (Baltimore, Md.)·2017
Same author

Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients.

Scientific reports·2017
Same author

Concurrent agglomeration and straining govern the transport of <sup>14</sup>C-labeled few-layer graphene in saturated porous media.

Water research·2017
Same author

Effects of temperature on graphene oxide deposition and transport in saturated porous media.

Journal of hazardous materials·2017
Same author

Computational Analysis of Intra-Ventricular Flow Pattern Under Partial and Full Support of BJUT-II VAD.

Medical science monitor : international medical journal of experimental and clinical research·2017
Same author

Inflammation is independent of steatosis in a murine model of steatohepatitis.

Hepatology (Baltimore, Md.)·2017

Related Experiment Video

Updated: Mar 22, 2026

Viability of Bioprinted Cellular Constructs Using a Three Dispenser Cartesian Printer
07:05

Viability of Bioprinted Cellular Constructs Using a Three Dispenser Cartesian Printer

Published on: September 22, 2015

10.6K

4D Bioprinting for Biomedical Applications.

Bin Gao1, Qingzhen Yang2, Xin Zhao2

  • 1Department of Endocrinology and Metabolism, Xijing Hospital, Fourth Military Medical University, 169 West Changle Road, Xi'an 710032, P.R. China.

Trends in Biotechnology
|April 9, 2016
PubMed
Summary

4D bioprinting integrates time with 3D bioprinting, enabling printed constructs to change shape or function over time. This review explores its advancements, applications in tissue engineering and drug delivery, and future challenges.

More Related Videos

Fabrication of Engineered Vascular Flaps Using 3D Printing Technologies
08:31

Fabrication of Engineered Vascular Flaps Using 3D Printing Technologies

Published on: May 19, 2022

4.7K
Bioprintable Alginate/Gelatin Hydrogel 3D In Vitro Model Systems Induce Cell Spheroid Formation
16:20

Bioprintable Alginate/Gelatin Hydrogel 3D In Vitro Model Systems Induce Cell Spheroid Formation

Published on: July 2, 2018

19.5K

Related Experiment Videos

Last Updated: Mar 22, 2026

Viability of Bioprinted Cellular Constructs Using a Three Dispenser Cartesian Printer
07:05

Viability of Bioprinted Cellular Constructs Using a Three Dispenser Cartesian Printer

Published on: September 22, 2015

10.6K
Fabrication of Engineered Vascular Flaps Using 3D Printing Technologies
08:31

Fabrication of Engineered Vascular Flaps Using 3D Printing Technologies

Published on: May 19, 2022

4.7K
Bioprintable Alginate/Gelatin Hydrogel 3D In Vitro Model Systems Induce Cell Spheroid Formation
16:20

Bioprintable Alginate/Gelatin Hydrogel 3D In Vitro Model Systems Induce Cell Spheroid Formation

Published on: July 2, 2018

19.5K

Area of Science:

  • Biotechnology
  • Regenerative Medicine
  • Materials Science

Background:

  • 3D bioprinting enables rapid patterning of cells and biomaterials for bioconstructs.
  • Direct cell/biomaterial contact via 3D bioprinting is insufficient for complex construct development.

Purpose of the Study:

  • To review recent advancements in 4D bioprinting technology.
  • To explore applications of 4D bioprinting in tissue engineering and drug delivery.
  • To discuss challenges and future perspectives in 4D bioprinting.

Main Methods:

  • Literature review of recent developments in 4D bioprinting.
  • Analysis of 4D bioprinting applications in tissue engineering and drug delivery.
  • Identification of major roadblocks and potential solutions.

Main Results:

  • 4D bioprinting introduces time as a fourth dimension, allowing dynamic changes in printed constructs.
  • Emerging applications in tissue engineering and drug delivery are highlighted.
  • Key challenges and potential solutions for the technology are discussed.

Conclusions:

  • 4D bioprinting represents a significant evolution from 3D bioprinting, enabling dynamic and responsive bioconstructs.
  • The technology holds promise for advanced tissue regeneration and targeted drug delivery systems.
  • Overcoming current limitations is crucial for realizing the full potential of 4D bioprinting.